2j15

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
|PDB= 2j15 |SIZE=350|CAPTION= <scene name='initialview01'>2j15</scene>
|PDB= 2j15 |SIZE=350|CAPTION= <scene name='initialview01'>2j15</scene>
|SITE=
|SITE=
-
|LIGAND=
+
|LIGAND= <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene>
|ACTIVITY=
|ACTIVITY=
|GENE=
|GENE=
 +
|DOMAIN=
 +
|RELATEDENTRY=
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2j15 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2j15 OCA], [http://www.ebi.ac.uk/pdbsum/2j15 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2j15 RCSB]</span>
}}
}}
Line 29: Line 32:
[[Category: toxin]]
[[Category: toxin]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 17:36:06 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 03:51:41 2008''

Revision as of 00:51, 31 March 2008


PDB ID 2j15

Drag the structure with the mouse to rotate
Ligands:
Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



CYCLIC MRIA: AN EXCEPTIONALLY STABLE AND POTENT CYCLIC CONOTOXIN WITH A NOVEL TOPOLOGICAL FOLD THAT TARGETS THE NOREPINEPHRINE TRANSPORTER.


Overview

Conotoxins, disulfide-rich peptides from the venom of cone snails, have created much excitement over recent years due to their potency and specificity for ion channels and their therapeutic potential. One recently identified conotoxin, MrIA, a 13-residue member of the chi-conotoxin family, inhibits the human norepinephrine transporter (NET) and has potential applications in the treatment of pain. In the current study, we show that the beta-hairpin structure of native MrIA is retained in a synthetic cyclic version, as is biological activity at the NET. Furthermore, the cyclic version has increased resistance to trypsin digestion relative to the native peptide, an intriguing result because the cleavage site for the trypsin is not close to the cyclization site. The use of peptides as drugs is generally hampered by susceptibility to proteolysis, and so, the increase in enzymatic stability against trypsin observed in the current study may be useful in improving the therapeutic potential of MrIA. Furthermore, the structure reported here for cyclic MrIA represents a new topology among a growing number of circular disulfide-rich peptides.

About this Structure

2J15 is a Single protein structure of sequence from [1]. Full crystallographic information is available from OCA.

Reference

Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter., Lovelace ES, Armishaw CJ, Colgrave ML, Wahlstrom ME, Alewood PF, Daly NL, Craik DJ, J Med Chem. 2006 Nov 2;49(22):6561-8. PMID:17064074

Page seeded by OCA on Mon Mar 31 03:51:41 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools